Table 2.
Baseline and follow‐up clinical characteristics
| Variable | Baseline | 14 days | P value | 6 months | P value |
|---|---|---|---|---|---|
| N = 10 | N = 10 | N = 10 | |||
| Systolic blood pressure (mmHg) | 117.4 ± 15.2 | 109.3 ± 8.6 | 0.128 | 124.1 ± 15.2 | 0.114 |
| Diastolic blood pressure (mmHg) | 73.3 ± 6.8 | 67.9 ± 7.4 | 0.201 | 73.5 ± 9.7 | 0.956 |
| QRS complex duration (ms) | 98.9 ± 14; r, 86–134 | 96.2 ± 9.9 | 0.902 | 104.1 ± 11.9; r, 96–134 | 0.078 |
| LVEF (%) | 31.8 ± 3.9; r, 26–35 | 39.8 ± 6.9 | 0.001 | 41.9 ± 9.0; r, 29–54 | 0.005 |
| LVEDd (mm) | 63.9 ± 3.2; r, 60–68 | 56.4 ± 3.3 | <0.001 | 57.6 ± 4.9; r, 53–68 | 0.005 |
| LVEDs (mm) | 50.9 ± 7.0; r, 40–59 | 43.3 ± 5.1 | 0.007 | 44.4 ± 7.0; r, 37–62 | 0.002 |
| 6 min walk distance (m) | 210.3 ± 38.5; r, 149–270 | 404.3 ± 49.0 | <0.001 | 418.5 ± 47.4; 300–493 | <0.001 |
| NYHA class, no. of patients (%) | III, 10 (100) | I, 7 (70) | 0.004 | I, 8 (80) | 0.002 |
| I/II, 1 (10) | II, 1 (10) | ||||
| II, 1 (10) | II/III, 1 (10) | ||||
| III, 1 (10) | |||||
| SF‐36 total score | |||||
| PCS | 41.0 ± 4.1 | 53.1 ± 3.4 | <0.001 | 57.2 ± 2.9 | <0.001 |
| MCS | 31.6 ± 8.6 | 57.7 ± 4.8 | <0.001 | 59.3 ± 4.8 | <0.001 |
LVEDd, left ventricular end‐diastolic diameter; LVEDs, left ventricular end‐systolic diameter; LVEF, left ventricular ejection fraction; MCS, Mental Component Summary; NYHA, New York Heart Association; PCS, Physical Component Summary; r, range; SF‐36, 36‐Item Short‐Form Health Survey questionnaire.
Values are presented as mean ± SD.